(Q33388983)

English

Pilot study of a (213)bismuth-labeled anti-CD45 mAb as a novel nonmyeloablative conditioning for DLA-haploidentical littermate hematopoietic transplantation

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Pilot study of a (213)bismuth-labeled anti-CD45 mAb as a novel nonmyeloablative conditioning for DLA-haploidentical littermate hematopoietic transplantation (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

7

object named as

Rainer Storb

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Brenda M Sandmaier

8

object named as

Brenda M Sandmaier

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Donald K Hamlin

5

object named as

Donald K Hamlin

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Erlinda B Santos

6

object named as

Erlinda B Santos

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Hirohisa Nakamae

1

object named as

Hirohisa Nakamae

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

author name string

Fabio R Kerbauy

2

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

D Scott Wilbur

3

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Wolfgang Bethge

4

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

language of work or name

0 references

publication date

1 June 2010

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

89

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

1336-1340

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Biodistributions, myelosuppression, and toxicities in mice treated with an anti-CD45 antibody labeled with the alpha-emitting radionuclides bismuth-213 or astatine-211

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2932447

21 June 2018

HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2932447

21 June 2018

131I-anti-CD45 antibody plus busulfan and cyclophosphamide before allogeneic hematopoietic cell transplantation for treatment of acute myeloid leukemia in first remission.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2932447

21 June 2018

Targeted cancer therapy using radiolabeled monoclonal antibodies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2932447

21 June 2018

Effects of a cloned cell line with NK activity on bone marrow transplants, tumour development and metastasis in vivo

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2932447

21 June 2018

Failure of allogeneic canine marrow grafts after total-body irradiation. Allogeneic "resistance" versus transfusion-induced sensitization.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2932447

21 June 2018

Bone marrow graft rejection as a function of antibody-directed natural killer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2932447

21 June 2018

Unmanipulated HLA 2-3 antigen-mismatched (haploidentical) bone marrow transplantation using only pharmacological GVHD prophylaxis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2932447

31 October 2018

Partially matched, nonmyeloablative allogeneic transplantation: clinical outcomes and immune reconstitution

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2932447

31 October 2018

Conditioning including antithymocyte globulin followed by unmanipulated HLA-mismatched/haploidentical blood and marrow transplantation can achieve comparable outcomes with HLA-identical sibling transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2932447

31 October 2018

Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2932447

31 October 2018

Radioimmunotherapy with bismuth-213 as conditioning for nonmyeloablative allogeneic hematopoietic cell transplantation in dogs: a dose deescalation study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2932447

31 October 2018

Selective T-cell ablation with bismuth-213-labeled anti-TCRalphabeta as nonmyeloablative conditioning for allogeneic canine marrow transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2932447

31 October 2018

Bismuth 213-labeled anti-CD45 radioimmunoconjugate to condition dogs for nonmyeloablative allogeneic marrow grafts

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2932447

31 October 2018

Transplantation of anergic histoincompatible bone marrow allografts

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2932447

31 October 2018

'Resistance' to unrelated, DLA-nonidentical canine marrow grafts is unrestricted by the major histocompatibility complex.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2932447

31 October 2018

Specific marrow localization of an 131I-labeled anti-myeloid antibody in normal dogs: effects of a "cold" antibody pretreatment dose on marrow localization

1 reference

https://pubmed.ncbi.nlm.nih.gov/20351629

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of (CA)n polymorphisms to determine the origin of blood cells after allogeneic canine marrow grafting

1 reference

https://pubmed.ncbi.nlm.nih.gov/20351629

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Development of a marrow transplant regimen for acute leukemia using targeted hematopoietic irradiation delivered by 131I-labeled anti-CD45 antibody, combined with cyclophosphamide and total body irradiation

1 reference

https://pubmed.ncbi.nlm.nih.gov/20351629

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Allogeneic transplant of canine peripheral blood stem cells mobilized by recombinant canine hematopoietic growth factors

1 reference

https://pubmed.ncbi.nlm.nih.gov/20351629

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Canine lymphoma: immunocytochemical analysis of fine-needle aspiration biopsy

1 reference

https://pubmed.ncbi.nlm.nih.gov/20351629

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Marrow ablative and immunosuppressive effects of 131I-anti-CD45 antibody in congenic and H2-mismatched murine transplant models

1 reference

https://pubmed.ncbi.nlm.nih.gov/20351629

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I study of (131)I-anti-CD45 antibody plus cyclophosphamide and total body irradiation for advanced acute leukemia and myelodysplastic syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/20351629

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1097/TP.0B013E3181D98C3D

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33388983&oldid=2120095649"